Latest Operating Expenses News

Prescient Therapeutics reported a 62.8% increase in half-year losses to nearly $4 million, driven by intensified clinical development of its PTX-100 cancer therapy. The company bolstered its balance sheet with a $9.85 million capital raise while securing key regulatory milestones in Europe and the US.

Nuchev Limited reported a 12% increase in revenue to $12.38 million for the half-year ended December 2025, driven by growth in core products and offshore markets. However, the company’s net loss widened to $2.34 million amid ongoing investments in marketing, product development, and international expansion.

333D Limited reported a 23% increase in revenue to $588,678 for the half-year ended December 2025, despite a 92% plunge in profit after tax to a $282,030 loss. The company boosted its cash reserves significantly and initiated a strategic Bitcoin investment.

Firebrick Pharma reports a reduced half-year loss of $1.26 million while launching its Nasodine Throat Spray in Singapore and Fiji, with regulatory approval pending in the Philippines.

QuickFee Limited has reported a dramatic turnaround with a $36.45 million profit in H1 FY26, driven by the sale of its US Pay Now business and a strategic capital return to shareholders. Underlying operations show promising growth despite divestments.

Tyro Payments Limited reported a solid 5% increase in gross profit and a 72% surge in statutory profit before tax for H1 FY26, underpinned by growth in core payment volumes and banking activities. The company also expanded its fintech footprint with the acquisition of AI-powered platform Thriday.

Nanosonics Limited reported a 9% revenue increase in the first half of FY26, driven by a growing installed base and recurring sales, while advancing the commercial rollout of its new CORIS endoscope reprocessing system.

hipages Group Holdings Ltd has delivered a robust half-year performance, reporting 11% revenue growth and a significant jump in net profit to A$2.75 million for the period ending December 2025. The company’s strategic pricing changes and expansion in New Zealand underpin this strong momentum.

Vulcan Steel reported an 8.6% revenue increase to NZ$535.4 million for the half-year ending December 2025, driven by its Roofing Industries acquisition and Steel segment growth, despite a 9.7% drop in net profit after tax.

NZME Limited has reported a significant turnaround in 2025, posting a statutory net profit after tax of NZD 13.1 million and a 15% increase in operating EBITDA, underpinned by strong digital revenue growth across its divisions.

Sequoia Financial Group reported a 75.9% jump in operating profit for 1H FY26 despite a net loss after non-operating charges, prompting a cautious dividend cut amid regulatory challenges.

EMVision Medical Devices reported a $3.97 million loss for H1 2026, up 11% year-on-year, driven by increased share-based payments and expanded clinical activities. The company secured a $3 million government grant to advance stroke diagnosis in regional Australia.